Skip to content
Posted on February 7, 2023 by: tove

宏光半导体宣布主要管理层之任命

Southeast Asia Chronicle
Posted on February 7, 2023 by: tove

宏光半导体宣布主要管理层之任命

  • Home
  • SEAPRWire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact

Tag: study

  • Home
  • study
Posted on February 2, 2023 by: remi

Mitsubishi Shipbuilding and INPEX Complete Conceptual Study for Ammonia Bunkering Vessel

TOKYO, Feb 2, 2023 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Shipbuilding Co., Ltd., a Mitsubishi Heavy Industries (MHI) Group company based in Yokohama, has …

Continue Reading
Posted on January 30, 2023 by: remi

Lecanemab Receives Priority Review Status in Japan

TOKYO and CAMBRIDGE, Mass., Jan 30, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that an application for …

Continue Reading
Posted on January 16, 2023 by: remi

Eisai Files Marketing Authorization Application for Anti-Amyloid-Beta Protofibril Antibody Lecanemab for Early Alzheimer’s Disease in Japan

TOKYO and CAMBRIDGE, Mass., Jan 16, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that Eisai has submitted …

Continue Reading
Posted on January 11, 2023 by: remi

Eisai Submits Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease in Europe

TOKYO, Jan 11, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that Eisai has submitted a …

Continue Reading
Posted on January 5, 2023 by: tove

HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations

ROCKVILLE, MD and SHENZHEN, CHINA, Jan 5, 2023 – (ACN Newswire via SEAPRWire.com) – HighTide Therapeutics Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing …

Continue Reading
Posted on December 7, 2022 by: remi

MHI Signs MoU with Chile’s Guacolda Energia for Feasibility Study of Ammonia Co-Firing at a Coal-Fired Thermal Power Plant

TOKYO, Dec 7, 2022 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Heavy Industries, Ltd. (MHI), on December 6, signed a Memorandum of Understanding (MoU) with …

Continue Reading
Posted on November 30, 2022 by: remi

Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai’s large global …

Continue Reading
Posted on November 30, 2022 by: remi

Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease in the New England Journal of Medicine

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai’s large global …

Continue Reading
Posted on November 17, 2022 by: tove

AJG Publishes Data from HighTide Therapeutics’ Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis

ROCKVILLE, MD and SHENZHEN, CHINA, Nov 17, 2022 – (ACN Newswire via SEAPRWire.com) – HighTide Therapeutics, Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing …

Continue Reading
Posted on November 17, 2022 by: tove

American Journal of Gastroenterology Publishes Data from HighTide Therapeutics’ Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis

ROCKVILLE, MD and SHENZHEN, CHINA, Nov 16, 2022 – (ACN Newswire via SEAPRWire.com) – HighTide Therapeutics, Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing …

Continue Reading
Posted on November 2, 2022 by: remi

Eisai Satisfies All-case Study Requirement for Antiepileptic Agent Inovelon

TOKYO, Nov 2, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has received notification from Japan’s Ministry of Health, …

Continue Reading
Posted on November 2, 2022 by: remi

Eisai Announces Plans to Submit Application for Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Based on Results of Drug Reexamination

TOKYO, Nov 2, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has received notification that Aricept (donepezil hydrochloride), a …

Continue Reading
Posted on August 24, 2022 by: tove

Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA

HONG KONG, Aug 24, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock …

Continue Reading
Posted on July 26, 2022 by: remi

Eisai to Present at The Alzheimer’s Association International Conference (AAIC) 2022

TOKYO, Jul 26, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co. Ltd announced today that the company will present research from its Alzheimer’s disease …

Continue Reading
Posted on July 20, 2022 by: tove

TrialWire Technology Platform Rolls Out World First SMS/Text Patient Contact System Across all Studies Globally

ADELAIDE, AUS, Jul 20, 2022 – (ACN Newswire via SEAPRWire.com) – TrialWire(TM) Technology Platform, the most secure and rapid digital patient recruitment Platform for trial …

Continue Reading
Posted on May 13, 2022 by: tove

Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine

SHANGHAI, CHINA, May 13, 2022 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, stock code on the main board of the Hong Kong …

Continue Reading
Posted on May 10, 2022 by: remi

Eisai Completes Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab for Early Alzheimer’s Disease Under the Accelerated Approval Pathway

TOKYO and CAMBRIDGE, Mass., May 10, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that Eisai has completed …

Continue Reading
Posted on April 19, 2022 by: remi

Joint Feasibility Study on the Commercialization of Sustainable Aviation Fuel

TOKYO, Apr 19, 2022 – (JCN Newswire via SEAPRWire.com) – ENEOS Corporation and Mitsubishi Corporation have agreed to undertake a joint feasibility study aimed at …

Continue Reading
Posted on March 27, 2022 by: ada

China’s Wang Yi visits Nepal, both sides to study feasibility of cross-border power grid

Continue Reading
Posted on March 22, 2022 by: remi

Eisai: Latest Findings on Lecanemab Presented at AD/PD 2022 Annual Meeting

CAMBRIDGE, Mass., and TOKYO, Mar 22, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the latest findings …

Continue Reading

Posts navigation

1 2 3

Categories

  • ACN Newswire
  • EQS Newswire
  • JCN Newswire
  • SEAPRWire

Latest News

  • 宏光半导体宣布主要管理层之任命 February 7, 2023
  • Doubleview Achieves Initial 56% Scandium Recovery in First Metallurgical Test of Hat Deposit Flotation Tailings – Potentially the First Major Source of Scandium in N. America February 7, 2023
  • Korindo Group Initiates First Rest Area with Bioconversion Facility in Indonesia February 7, 2023
  • Celebverse launches VR Apparel Store and Night Club to transform Fashion and Entertainment February 7, 2023
  • Palladium One Expands West Pickle High-Grade Nickel Zone to 600 Meters, Tyko Nickel – Copper Project, Canada February 6, 2023
  • Moonstake Partners with Humans.ai to Help Advance Artificial Intelligence on the Blockchain and Support the AI Startup’s Expansion in Asia February 6, 2023
  • HKTDC: Hong Kong ready for business; Delegation arrives in Riyadh February 6, 2023
  • 多项经营指标超预期 兔年春节万达集团喜迎开门红 February 6, 2023
  • Fujitsu Launches New Platform to Support Web3 Developers Globally February 6, 2023
  • JCB and Vietnam Prosperity Joint Stock Commercial Bank launch VPBank JCB Credit Card with a focus on Generation Z in Viet Nam February 6, 2023
  • Sunway RE Capital Expands Student Accommodation Portfolio with New Acquisition of Freehold Purpose-Built Student Accommodation, Green Wood Court, in Southampton, UK February 6, 2023
  • Abraclean Launches Singapore’s First Recycled Glass Abrasive Plant February 6, 2023
  • Subang Parade Celebrates CNY with Persatuan Rumah K.I.D.S and Rumah Charis February 4, 2023
  • Malabar Gold & Diamonds Continues Rapid Expansion; Opens its 300th Global Showroom in Dallas, USA February 4, 2023
  • 亚太地区细胞与基因研究:Novotech 的增长速度比世界其它地区快 50% February 4, 2023

Menu

  • Home
  • About Us
  • Contact Us
  • Term of Use
  • RSS

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
Copyright © 2023 Southeast Asia Chronicle All Rights Reserved By Seachronicle.Com